{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:39:19Z","timestamp":1792492759651,"version":"4.5.0"},"reference-count":61,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Dutch Cancer Society (Koningin Wilhelmina Fonds","award":["14485"],"award-info":[{"award-number":["14485"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjopen-2026-128210","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:46:14Z","timestamp":1792489574000},"page":"e128210","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating [\n                    <sup>18<\/sup>\n                    F]-AlF-FAPI-74 PET\/CT for diagnosis of the unfavourable CMS4 colorectal cancer subtype (FoCus study): protocol for a prospective, observational, proof-of-concept clinical study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06191120","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06640413","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05400967","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04939610","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7049-7781","authenticated-orcid":false,"given":"Maurice","family":"van Duijvenvoorde","sequence":"first","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, Department of Epidemiology and Health Economic Evaluation, University Medical Centre Utrecht, Utrecht, The Netherlands"},{"name":"Division of Imaging and Cancer, Laboratoy Translational Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno","family":"Kranenburg","sequence":"additional","affiliation":[{"name":"Division of Imaging and Cancer, Laboratoy Translational Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-8461","authenticated-orcid":false,"given":"Myrna","family":"van den Bos","sequence":"additional","affiliation":[{"name":"Division of Imaging and Cancer, Laboratoy Translational Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hagendoorn","sequence":"additional","affiliation":[{"name":"Division of Imaging and Cancer, Laboratoy Translational Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"},{"name":"Division of Imaging and Cancer, Department of Surgical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine M L","family":"Roodhart","sequence":"additional","affiliation":[{"name":"Division of Imaging and Cancer, Laboratoy Translational Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"},{"name":"Division of Imaging and Cancer, Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya N","family":"Milne","sequence":"additional","affiliation":[{"name":"Department of Pathology, St Antonius Hospital, Nieuwegein, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W","family":"te Riele","sequence":"additional","affiliation":[{"name":"Department of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne M","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger-Jan","family":"Swijnenburg","sequence":"additional","affiliation":[{"name":"Department of Surgery, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Arensman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Meander Medical Centre, Amersfoort, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Verheijen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Meander Medical Centre, Amersfoort, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandi H W","family":"Schiphorst","sequence":"additional","affiliation":[{"name":"Department of Surgery, Diakonessenhuis Utrecht Zeist Doorn Locatie Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kool","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Cyclotron Noordwest B.V, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Ververs","sequence":"additional","affiliation":[{"name":"Department of Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"De Keizer","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miangela M","family":"Lacle","sequence":"additional","affiliation":[{"name":"Department of Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnix G E H","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd G","family":"Elias","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, Department of Epidemiology and Health Economic Evaluation, University Medical Centre Utrecht, Utrecht, The Netherlands"},{"name":"Division of Imaging and Cancer, Laboratoy Translational Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102002454432000_16.10.e128210.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026102002454432000_16.10.e128210.2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","article-title":"From tumour heterogeneity to advances in precision treatment of colorectal cancer","volume":"14","author":"Punt","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2026102002454432000_16.10.e128210.3","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3967"},{"key":"2026102002454432000_16.10.e128210.4","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ijc.33003","article-title":"Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis","volume":"147","author":"Schlicker","year":"2020","journal-title":"Int J Cancer"},{"key":"2026102002454432000_16.10.e128210.5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamaoncol.2016.2314","article-title":"Clinical Outcome From Oxaliplatin Treatment in Stage II\/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07\/NRG Oncology Randomized Clinical Trial","volume":"2","author":"Song","year":"2016","journal-title":"JAMA Oncol"},{"key":"2026102002454432000_16.10.e128210.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0680"},{"key":"2026102002454432000_16.10.e128210.7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab106"},{"key":"2026102002454432000_16.10.e128210.8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1200\/JCO-25-00596","article-title":"Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer","volume":"44","author":"Stahler","year":"2026","journal-title":"J Clin Oncol"},{"key":"2026102002454432000_16.10.e128210.9","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.48","article-title":"Neoadjuvant chemotherapy affects molecular classification of colorectal tumors","volume":"6","author":"Trumpi","year":"2017","journal-title":"Oncogenesis"},{"key":"2026102002454432000_16.10.e128210.10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz052"},{"key":"2026102002454432000_16.10.e128210.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07316-z","article-title":"Interconnectivity between molecular subtypes and tumor stage in colorectal cancer","volume":"20","author":"Coebergh van den Braak","year":"2020","journal-title":"BMC Cancer"},{"key":"2026102002454432000_16.10.e128210.12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0032"},{"key":"2026102002454432000_16.10.e128210.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0529"},{"key":"2026102002454432000_16.10.e128210.14","doi-asserted-by":"crossref","unstructured":"Ubink I , Elias SG , Moelans CB , et al . A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity. J Natl Cancer Inst 2017;109. doi:10.1093\/jnci\/djw303","DOI":"10.1093\/jnci\/djw303"},{"key":"2026102002454432000_16.10.e128210.15","doi-asserted-by":"crossref","unstructured":"Seligmann JF , Seymour MT . Use of Gene Expression Profiles to Distinguish Molecular Subtypes in Colorectal Cancer: Progression Toward Primetime. J Natl Cancer Inst 2017;109. doi:10.1093\/jnci\/djx019","DOI":"10.1093\/jnci\/djx019"},{"key":"2026102002454432000_16.10.e128210.16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3032"},{"key":"2026102002454432000_16.10.e128210.17","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/1878-0261.13210","article-title":"Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes","volume":"16","author":"Adam","year":"2022","journal-title":"Mol Oncol"},{"key":"2026102002454432000_16.10.e128210.18","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7765-9_11"},{"key":"2026102002454432000_16.10.e128210.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319866"},{"key":"2026102002454432000_16.10.e128210.20","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202402730","article-title":"A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues","volume":"7","author":"de Back","year":"2024","journal-title":"Life Sci Alliance"},{"key":"2026102002454432000_16.10.e128210.21","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1002\/bjs.10788","article-title":"Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases","volume":"105","author":"Ubink","year":"2018","journal-title":"Br J Surg"},{"key":"2026102002454432000_16.10.e128210.22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.969855","article-title":"Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study","volume":"12","author":"Peters","year":"2022","journal-title":"Front Oncol"},{"key":"2026102002454432000_16.10.e128210.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-025-04117-1","article-title":"Consensus Molecular Subtypes (CMS) Classification: a progress towards Subtype-Driven treatments in colorectal cancer","volume":"24","author":"Kantha","year":"2025","journal-title":"World J Surg Oncol"},{"key":"2026102002454432000_16.10.e128210.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210443"},{"key":"2026102002454432000_16.10.e128210.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210435"},{"key":"2026102002454432000_16.10.e128210.26","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-021-00144-x","article-title":"18F-labeled tracers targeting fibroblast activation protein","volume":"6","author":"Lindner","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"key":"2026102002454432000_16.10.e128210.27","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1007\/s00330-023-09715-9","article-title":"68Ga- or 18F-FAPI PET\/CT\u2014what it can and cannot","volume":"33","author":"Mori","year":"2023","journal-title":"Eur Radiol"},{"key":"2026102002454432000_16.10.e128210.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0275-3"},{"key":"2026102002454432000_16.10.e128210.29","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0340"},{"key":"2026102002454432000_16.10.e128210.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01748-z"},{"key":"2026102002454432000_16.10.e128210.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4153-6"},{"key":"2026102002454432000_16.10.e128210.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.08.003"},{"key":"2026102002454432000_16.10.e128210.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.245084"},{"key":"2026102002454432000_16.10.e128210.34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265486"},{"key":"2026102002454432000_16.10.e128210.35","doi-asserted-by":"publisher","DOI":"10.2307\/2533958"},{"key":"2026102002454432000_16.10.e128210.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5"},{"key":"2026102002454432000_16.10.e128210.37","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00004"},{"key":"2026102002454432000_16.10.e128210.38","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7163"},{"key":"2026102002454432000_16.10.e128210.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.02.003"},{"key":"2026102002454432000_16.10.e128210.40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24617"},{"key":"2026102002454432000_16.10.e128210.41","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100073","article-title":"Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study","volume":"6","author":"Borelli","year":"2021","journal-title":"ESMO Open"},{"key":"2026102002454432000_16.10.e128210.42","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-021-01464-3","article-title":"Dual inhibition of TGF\u03b2 and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype","volume":"38","author":"Ciardiello","year":"2021","journal-title":"Med Oncol"},{"key":"2026102002454432000_16.10.e128210.43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317101","article-title":"Targeting the TGF-\u03b2 Signaling Axis in Metastatic Colorectal Cancer: Where Do We Stand?","volume":"24","author":"Papavassiliou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026102002454432000_16.10.e128210.44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091282","article-title":"Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture","volume":"11","author":"Bailly","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2026102002454432000_16.10.e128210.45","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.239731"},{"key":"2026102002454432000_16.10.e128210.46","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-021-05273-8","article-title":"[153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma","volume":"48","author":"Kratochwil","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026102002454432000_16.10.e128210.47","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259192"},{"key":"2026102002454432000_16.10.e128210.48","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/RLU.0000000000003678","article-title":"Theranostic Approach in Breast Cancer: A Treasured Tailor for Future Oncology","volume":"46","author":"Jokar","year":"2021","journal-title":"Clin Nucl Med"},{"key":"2026102002454432000_16.10.e128210.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262468"},{"key":"2026102002454432000_16.10.e128210.50","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00259-020-04990-w","article-title":"A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET\/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy","volume":"48","author":"Ballal","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026102002454432000_16.10.e128210.51","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/ph14121212","article-title":"First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2","volume":"14","author":"Ballal","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026102002454432000_16.10.e128210.52","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1097\/RLU.0000000000004164","article-title":"First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer","volume":"47","author":"Ballal","year":"2022","journal-title":"Clin Nucl Med"},{"key":"2026102002454432000_16.10.e128210.53","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268200"},{"key":"2026102002454432000_16.10.e128210.54","doi-asserted-by":"crossref","first-page":"14574969221083144","DOI":"10.1177\/14574969221083144","article-title":"Does 18F-FDG PET\/CT change the surgical management of potentially resectable colorectal liver metastases?","volume":"111","author":"Jonsson","year":"2022","journal-title":"Scand J Surg"},{"key":"2026102002454432000_16.10.e128210.55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.2020203275","article-title":"Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers","volume":"298","author":"Pang","year":"2021","journal-title":"Radiology"},{"key":"2026102002454432000_16.10.e128210.56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/RLU.0000000000004480","article-title":"Impact of 68Ga-FAPI-04 PET\/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors","volume":"48","author":"Kosmala","year":"2023","journal-title":"Clin Nucl Med"},{"key":"2026102002454432000_16.10.e128210.57","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266652"},{"key":"2026102002454432000_16.10.e128210.58","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11307-022-01729-x","article-title":"Comparison of 68Ga-FAPI PET\/CT and 18FDG PET\/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement","volume":"24","author":"Elboga","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"2026102002454432000_16.10.e128210.59","doi-asserted-by":"crossref","first-page":"109867","DOI":"10.1016\/j.ejrad.2021.109867","article-title":"Comparison of 68Ga-DOTA-FAPI and 18FDG PET\/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer","volume":"142","author":"\u015eahin","year":"2021","journal-title":"Eur J Radiol"},{"key":"2026102002454432000_16.10.e128210.60","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C"},{"key":"2026102002454432000_16.10.e128210.61","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2408-z"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-128210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:46:19Z","timestamp":1792489579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-128210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,20]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjopen-2026-128210"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-128210","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}